Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

CaMKKβ Inhibitors

CaMKKβ inhibitors comprise a specific category of chemical compounds intricately designed to selectively modulate the activity of Calcium/Calmodulin-Dependent Protein Kinase Kinase Beta (CaMKKβ). CaMKKβ is a crucial enzyme involved in cellular signaling, particularly in the context of calcium-dependent pathways. These inhibitors function by binding to CaMKKβ, thereby triggering intricate alterations in its enzymatic activity, which primarily involves the phosphorylation of target proteins, especially those in downstream signaling cascades. These inhibitors are carefully crafted to engage with well-defined binding pockets on the CaMKKβ enzyme, disrupting its natural interactions with substrates and co-regulatory molecules. Consequently, this binding interaction interferes with the enzyme's ability to phosphorylate target proteins, leading to downstream effects on cellular processes driven by CaMKKβ-mediated signaling.

The development of CaMKKβ inhibitors requires a multifaceted approach, integrating structural insights, computational analysis, and chemical synthesis to engineer compounds with optimal binding characteristics for CaMKKβ. This process necessitates a comprehensive understanding of the enzyme's structural features and its intricate interactions with substrates and cofactors. Through iterative design, synthesis, and thorough evaluation, the aim is to generate inhibitors with the capacity to effectively perturb CaMKKβ's enzymatic function. As scientific exploration of CaMKKβ inhibitors advances, researchers strive to unravel the nuanced mechanisms underpinning the interaction between these inhibitors and the enzyme. A comprehensive comprehension of these mechanisms holds the promise of shedding light on the broader realm of intracellular signaling pathways, revealing new insights into cellular responses governed by CaMKKβ-mediated phosphorylation events. By delving into the intricacies of CaMKKβ inhibition, scientists endeavor to deepen our understanding of the intricate orchestration of cellular communication and uncover novel perspectives in the domain of cellular signaling.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

BML-275

866405-64-3sc-200689
sc-200689A
5 mg
25 mg
$96.00
$355.00
69
(1)

Primarily known as an AMPK inhibitor, BML-275 (Compound C) indirectly impacts CaMKKβ by blocking the AMPK pathway, a key downstream effector, potentially reducing CaMKKβ-mediated signaling involved in cellular energy regulation.

STO-609

52029-86-4sc-507444
5 mg
$140.00
(0)

STO-609 is a small molecule compound known for its specific inhibition of CAMKKβ activity, with potential applications in AMPK and CaMK signaling regulation.

KN-93

139298-40-1sc-202199
1 mg
$182.00
25
(1)

Though KN-93 is primarily a CaMKII inhibitor, it has been shown to indirectly affect CaMKKβ activity by inhibiting downstream pathways that are common to both kinases, impacting cellular processes such as calcium signaling and neurotransmission.

Indirubin-3′-monoxime

160807-49-8sc-202660
sc-202660A
sc-202660B
1 mg
5 mg
50 mg
$79.00
$321.00
$671.00
1
(1)

A broad-spectrum kinase inhibitor that can indirectly affect CaMKKβ by inhibiting several downstream targets within the CaMKKβ signaling network, thereby potentially reducing its overall activity on cellular functions.

H-89 dihydrochloride

130964-39-5sc-3537
sc-3537A
1 mg
10 mg
$94.00
$186.00
71
(2)

While H-89 is known as a PKA inhibitor, it also shows inhibition of other kinases, potentially affecting CaMKKβ's downstream signaling cascades, particularly in pathways involved in memory and learning.

IC261

186611-52-9sc-3561
5 mg
$140.00
11
(1)

Initially identified as a CK1 inhibitor, IC261 has been noted to affect various kinases and may indirectly impact CaMKKβ activity by modulating downstream signaling pathways related to cellular stress responses.